Tackling Uncertainty: Targeted Risk Assessment & Management for High-Quality HPAPI
Time: 2:00 pm
day: Conference Day Two
Details:
- Building a step-by-step guide on how to create quality standards for impurity manufacturing
- Spotlighting US Pharmacopeia’s approach to handling various impurities in-house
- Leveraging our symbiotic relationship with the FDA to minimize risk based on the evolving regulatory landscape
